ResearcherActive in the last 2 years
Mary Beth Nierengarten
Matched on OpenAlex author ID A5068740896.
Their work
- Papers
- 6 (first author 6, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 0
2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 6
- Long-term outcomes of GemCap for pancreatic ductal adenocarcinoma: GemCap proves to be a standard option for patients not eligible for mFOLFIRINOX. First author DOI 10.1002/cncr.35923↗
- First person profile: Eileen M. O'Reilly, MD: Dr O'Reilly's research has resulted in the first new therapy in more than a decade for treatment-naïve metastatic… First author DOI 10.1002/cncr.35554↗
- Annual report to the nation on the status of cancer: This latest report, a collaboration from the American Cancer Society, the Centers for Disease Control and … First author DOI 10.1002/cncr.34586↗
- Staging laparoscopy before therapy for pancreatic cancer is valuable. First author DOI 10.1002/cncr.35054↗
- Aggressive surgical approach for stage II pancreatic cancer. First author DOI 10.1002/cncr.33785↗
- Rucaparib is a safe and effective maintenance therapy for advanced pancreatic cancer. First author DOI 10.1002/cncr.33883↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.